Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
- PMID:19234110
- PMCID: PMC2656143
- DOI: 10.1073/pnas.0812874106
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Abstract
Although it has long been recognized that the enteric community of bacteria that inhabit the human distal intestinal track broadly impacts human health, the biochemical details that underlie these effects remain largely undefined. Here, we report a broad MS-based metabolomics study that demonstrates a surprisingly large effect of the gut "microbiome" on mammalian blood metabolites. Plasma extracts from germ-free mice were compared with samples from conventional (conv) animals by using various MS-based methods. Hundreds of features were detected in only 1 sample set, with the majority of these being unique to the conv animals, whereas approximately 10% of all features observed in both sample sets showed significant changes in their relative signal intensity. Amino acid metabolites were particularly affected. For example, the bacterial-mediated production of bioactive indole-containing metabolites derived from tryptophan such as indoxyl sulfate and the antioxidant indole-3-propionic acid (IPA) was impacted. Production of IPA was shown to be completely dependent on the presence of gut microflora and could be established by colonization with the bacterium Clostridium sporogenes. Multiple organic acids containing phenyl groups were also greatly increased in the presence of gut microbes. A broad, drug-like phase II metabolic response of the host to metabolites generated by the microbiome was observed, suggesting that the gut microflora has a direct impact on the drug metabolism capacity of the host. Together, these results suggest a significant interplay between bacterial and mammalian metabolism.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
- Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.Xie G, Zhang S, Zheng X, Jia W.Xie G, et al.Electrophoresis. 2013 Oct;34(19):2787-98. doi: 10.1002/elps.201300017. Epub 2013 Aug 16.Electrophoresis. 2013.PMID:23775228Review.
- Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition.Zarei I, Koistinen VM, Kokla M, Klåvus A, Babu AF, Lehtonen M, Auriola S, Hanhineva K.Zarei I, et al.Sci Rep. 2022 Sep 2;12(1):15018. doi: 10.1038/s41598-022-19327-w.Sci Rep. 2022.PMID:36056162Free PMC article.
- Evaluating effects of penicillin treatment on the metabolome of rats.Sun J, Schnackenberg LK, Khare S, Yang X, Greenhaw J, Salminen W, Mendrick DL, Beger RD.Sun J, et al.J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:134-43. doi: 10.1016/j.jchromb.2013.05.030. Epub 2013 Jun 7.J Chromatogr B Analyt Technol Biomed Life Sci. 2013.PMID:23831706
- Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.Liu Y, Li J, Yu J, Wang Y, Lu J, Shang EX, Zhu Z, Guo J, Duan J.Liu Y, et al.J Pharm Biomed Anal. 2018 Feb 5;149:425-435. doi: 10.1016/j.jpba.2017.11.040. Epub 2017 Nov 15.J Pharm Biomed Anal. 2018.PMID:29169110
- Indolic Structure Metabolites as Potential Biomarkers of Non-infectious Diseases.Beloborodova NV, Chernevskaya EA, Getsina ML.Beloborodova NV, et al.Curr Pharm Des. 2021;27(2):238-249. doi: 10.2174/1381612826666201022121653.Curr Pharm Des. 2021.PMID:33092503Review.
Cited by
- Mixture Effects of Tryptophan Intestinal Microbial Metabolites on Aryl Hydrocarbon Receptor Activity.Vrzalová A, Pečinková P, Illés P, Gurská S, Džubák P, Szotkowski M, Hajdúch M, Mani S, Dvořák Z.Vrzalová A, et al.Int J Mol Sci. 2022 Sep 16;23(18):10825. doi: 10.3390/ijms231810825.Int J Mol Sci. 2022.PMID:36142735Free PMC article.
- Chapter 12: Human microbiome analysis.Morgan XC, Huttenhower C.Morgan XC, et al.PLoS Comput Biol. 2012;8(12):e1002808. doi: 10.1371/journal.pcbi.1002808. Epub 2012 Dec 27.PLoS Comput Biol. 2012.PMID:23300406Free PMC article.
- Clinical metabolomics paves the way towards future healthcare strategies.Collino S, Martin FP, Rezzi S.Collino S, et al.Br J Clin Pharmacol. 2013 Mar;75(3):619-29. doi: 10.1111/j.1365-2125.2012.04216.x.Br J Clin Pharmacol. 2013.PMID:22348240Free PMC article.Review.
- Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells.McCarthy NE, Stagg AJ, Price CL, Mann ER, Gellatly NL, Al-Hassi HO, Knight SC, Panoskaltsis N.McCarthy NE, et al.Cancer Immunol Immunother. 2021 Apr;70(4):1143-1153. doi: 10.1007/s00262-020-02723-4. Epub 2020 Oct 13.Cancer Immunol Immunother. 2021.PMID:33048222Free PMC article.Clinical Trial.
- The trace aminergic system: a gender-sensitive therapeutic target for IBS?Pretorius L, Smith C.Pretorius L, et al.J Biomed Sci. 2020 Sep 28;27(1):95. doi: 10.1186/s12929-020-00688-1.J Biomed Sci. 2020.PMID:32981524Free PMC article.Review.
References
- Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–1920. - PubMed
- Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107–118. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical